By Kamal Choudhury and Michael Erman March 6 (Reuters) - The controversial head of the U.S. Food and Drug Administration's vaccines and biologics unit, Dr. Vinay Prasad, will leave the agency at the ...
Vinay Prasad, director of the Center for Biologics Evaluation and Research, will leave the FDA at the end of April, an agency ...
Opinion
23hOpinion
We Lost the Lyme Vaccine. Under Rand Paul's New Vaccine Liability Bill, We'll Lose More.
The End the Vaccine Carveout Act would expose vaccine makers to lawsuits that once drove companies out of the industry.
About four years after the case was filed—and against the backdrop of a significantly changed COVID-19 vaccine ...
A Single Shot to Shield Against Two Viruses: EMA Poised to Approve Moderna’s COVID-Flu Combo Vaccine
EMA backs Moderna’s dual COVID-19 and flu vaccine, mCombriax, paving the way for EU approval ahead of the 2026–2027 season.
Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
Fact check - There is no link between the discovery of cancer treatments and vaccines and the US leaving the WHO.
In this week’s edition of InnovationRx, we look at the startup that wants to treat Alzheimer’s with microrobots, medical ...
Lantern announced partnerships with Novant Health and EmergeOrtho as part of its ongoing collaboration with the North Carolina State Health Plan. Nanox is collaborating with three new partners to ...
According to Budiman, more than 125 countries have included the HPV vaccine in their national immunization programs. Research ...
Vietnam has launched clinical trials of a new antiviral drug that could offer fresh hope in the fight against dengue fever, a disease that still has no approved specific treatment worldwide.
Individuals share their journeys battling cancer and their experiences with groundbreaking immunotherapy treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results